Extracorporeal Low-intensity Shockwave in Diabetic Nephropathy

Status Recruiting

Clinical Trial Summary

In the current study, we use extracorporeal low-intensity shockwave therapy (ESWT) to treat on patients with type 2 diabetes in stage 3-4 chronic kidney disease and see whether it can improve the proteinuria, renal function, and blood pressure compared to baseline and control group.

Clinical Trial Description

Diabetic nephropathy is the major contributor to end stage renal disease worldwide. Extracorporeal shock wave treatments (ESWT) with low-intensity was reported to be beneficial in inducing cell regeneration and reducing inflammation and have been successfully used for bone fracture, cardiac ischemia, and erectile disorders. In this study, sixty patients with stage III & IV (15<=estimated glomerular filtration rate (eGFR)<60 ml/min/1.73m2) will be recruited and allocated to control and experimental groups in a 1:1 ratio. In experiment group, a total of 1200 shockwaves, with low energy density 0.1mj/mm2 and a frequency of 120 shocks/min, will be applied per kidney per treatment session. The treatment will be given twice a week for 3 consecutive weeks, followed by 3 weeks of recess and an additional series of 6 sessions (totally 12 times). Patients in each group will be evaluated with eGFR, urine protein-creatinine ration, blood pressure, and biochemistry data at the beginning (index day) and 12 months after starting of the therapy. (Outcome time point: 12 months) ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03445247
Study type	Interventional
Source	Chang Gung Memorial Hospital
Contact	Lung-Chih Li, MD, PhD.
Phone	886-7-7317123
Email	longee01@gmail.com
Status	Recruiting
Phase	N/A
Start date	July 1, 2017
Completion date	June 30, 2020

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT03840343` - Patient-Derived Stem Cell Therapy for Diabetic Kidney Disease	Phase 1
Completed	`NCT04549324` - Sleep Apnea, Coronary Atherosclerosis and Heart Failure in Diabetes Patients With Nephropathy
Recruiting	`NCT03502031` - Safety and Efficacy of Two Year of RAAS Alone or in Combination With Spironolactone Therapy	Phase 4
Completed	`NCT03681704` - the Integrated Traditional Chinese and Western Medicine Treat Early Stage DKD	Phase 1
Completed	`NCT03681249` - the Integrated Traditional Chinese and Western Medicine Treat Middle Stage DKD	Early Phase 1
Withdrawn	`NCT03504566` - Rotation for Optimal Targeting of Albuminuria and Treatment Evaluation (ROTATE-2)	Phase 4
Completed	`NCT03889236` - Dietary Interventions on Glycocalyx Dimensions in South Asian Patients With Diabetic Nephropathy.	N/A
Completed	`NCT06326034` - Impact of Dapagliflozin as Add-on Therapy on Glycemic Status and Quality of Life in Type 2 Diabetic Patients	Phase 4
Recruiting	`NCT04931537` - Screening and Application Research of Early Diabetic Nephropathy Markers Based on Lipidomics.
Not yet recruiting	`NCT05373004` - Comparison Between the Efficacy of SGLT2 Inhibitor Therapy Versus ACE Inhibitor in the Treatment of Diabetic Kidney Disease	Phase 2/Phase 3
Recruiting	`NCT03622762` - Green Tea Extract on Soluble RAGE in Patients With Diabetic Nephropathy	Phase 2
Not yet recruiting	`NCT06068439` - Study of the Protective Effect of Low-dose Aspirin on Renal Function in Patients With Early Diabetic Nephropathy	Phase 2/Phase 3
Active, not recruiting	`NCT05487755` - Investigational and Comparative Study in the Management of Diabetic Nephropathy	Phase 3
Recruiting	`NCT04143412` - Efficacy of ACE Inhibitors, MRAs and ACE Inhibitor/ MRA Combination	Phase 2
Not yet recruiting	`NCT06222476` - Effect of Dorzagliatin on Renal Function Outcomes in People With Type 2 Diabetes: a Multicentric, Prospective, Randomized Study.	N/A
Active, not recruiting	`NCT04573920` - Atrasentan in Patients With Proteinuric Glomerular Diseases	Phase 2
Recruiting	`NCT05888909` - Multidimensional Accurate Diagnosis and Treatment Technology and Clinical Transformation of Type 2 Diabetes Nephropathy
Not yet recruiting	`NCT04962399` - Relationship Between Serum N/OFQ and Type 2 Diabetic Nephropathy
Not yet recruiting	`NCT03591939` - T-regulatory Cells in Diabetic Type Two Nephropathy
Active, not recruiting	`NCT03859817` - Observational Study to Evaluate the Relationship Between Ketonemia and Renal Function in the Diabetic Patient